Chiroscience Group - Compulsory Acqn Procedure
16 Agosto 1999 - 5:42PM
UK Regulatory
RNS No 781r
CHIROSCIENCE GROUP PLC
16 August 1999
Not for release, publication or distribution in or into the United States,
Canada, Australia or Japan
Celltech Chiroscience plc ("Celltech")
Recommended Merger Offer for
Chiroscience Group plc ("Chiroscience")
Level of Acceptances and Issue of Section 429 Notices
By 3.00 p.m. on 13 August 1999, valid acceptances of the Merger Offer had been
received in respect of 103,807,411 Chiroscience Shares, representing 90.15 per
cent. of the issued ordinary share capital of Chiroscience.
Accordingly, Celltech now intends to exercise its right pursuant to sections
428 to 430F of the Companies Act 1985 to compulsorily acquire any outstanding
Chiroscience Shares to which the Merger Offer relates which it has not yet
acquired or contracted to acquire. Section 429 notices will be despatched
shortly to Chiroscience Shareholders who have not yet accepted the Merger
Offer.
The Merger Offer remains open for acceptance and will continue to remain open
throughout the compulsory acquisition notice period.
Enquiries:
Celltech Chiroscience plc
Peter Allen, Chief Operating Officer Tel : 01753 534 655
Christine Soden, Chief Financial Officer
Flemings
Simon Gorringe Tel : 0171 638 5858
Terms defined in the Merger Offer Document dated 6 July 1999 have the same
meaning in this press release.
Flemings, which is regulated in the UK by The Securities and Futures Authority
Limited, is acting for Celltech and no one else in connection with the Merger
Offer and will not be responsible to anyone other than Celltech for providing
the protections afforded to customers of Flemings or for providing advice in
relation to the Merger Offer.
This announcement has been approved by Flemings for the purposes of section 57
of the Financial Services Act 1986.
END
OFFSFEFIMUUUFEA
Grafico Azioni Amedeo Res (LSE:AMED)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Amedeo Res (LSE:AMED)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Amedeo Res (Borsa di Londra): 0 articoli recenti
Più Chiroscience Group Articoli Notizie